"Most view" Articles are updated quarterly. Below are Intest Res’s most frequently accessed articles for the previous last months.

Original Articles WITHDRAWN:Knowledge and viewpoints on biosimilar monoclonal antibodies from members of the Asian Organization of Crohn’s and Colitis: comparison with European Crohn’s and Colitis members

Soo-Kyung Park, Tadakazu Hisamatsu, Zhihua Ran, Shu-Chen Wei, Dong Il Park

Editorials Risk Factors for Delayed Recurrence of Clostridium difficile Infection

Ji Won Kim

Intest Res. 2014;12(4):266-267.

Reviews Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease

Himani Pandey, Dheeraj Jain, Daryl W. T. Tang, Sunny H. Wong, Devi Lal

Intest Res. 2024;22(1):15-43.

Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease

Himani Pandey, Dheeraj Jain, Daryl W. T. Tang, Sunny H. Wong, Devi Lal

Intest Res. 2024;22(1):15-43.

Editorials Which biomarkers best reflect the degree of inflammation in Crohn’s disease?

Jihye Park

Intest Res. 2024;22(1):1-2.

Reviews Second Korean guidelines for the management of ulcerative colitis

Chang Hwan Choi, Won Moon, You Sun Kim, Eun Soo Kim, Bo-In Lee, Yunho Jung, Yong Sik Yoon, Heeyoung Lee, Dong Il Park, Dong Soo Han

Intest Res. 2017;15(1):7-37.

Statement Clinical practice guideline for endoscopic resection of early gastrointestinal cancer

Chan Hyuk Park, Dong-Hoon Yang, Jong Wook Kim, Jie-Hyun Kim, Ji Hyun Kim, Yang Won Min, Si Hyung Lee, Jung Ho Bae, Hyunsoo Chung, Kee Don Choi, Jun Chul Park, Hyuk Lee, Min-Seob Kwak, Bun Kim, Hyun Jung Lee, Hye Seung Lee, Miyoung Choi, Dong-Ah Park, Jong Yeul Lee, Jeong-Sik Byeon, Chan Guk Park, Joo Young Cho, Soo Teik Lee, Hoon Jai Chun

Intest Res. 2021;19(2):127-157.

Reviews Second Korean guidelines for the management of Crohn's disease

Jae Jun Park, Suk-Kyun Yang, Byong Duk Ye, Jong Wook Kim, Dong Il Park, Hyuk Yoon, Jong Pil Im, Kang Moon Lee, Sang Nam Yoon, Heeyoung Lee

Intest Res. 2017;15(1):38-67.

Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia

Choon Jin Ooi, Ida Hilmi, Rupa Banerjee, Sai Wei Chuah, Siew Chien Ng, Shu Chen Wei, Govind K Makharia, Pises Pisespongsa, Min Hu Chen, Zhi Hua Ran, Byong Duk Ye, Dong Il Park, Khoon Lin Ling, David Ong, Vineet Ahuja, Khean Lee Goh, Jose Sollano, Wee Chian Lim, Wai Keung Leung, Raja Affendi Raja Ali, Deng Chyang Wu, Evan Ong, Nazri Mustaffa, Julajak Limsrivilai, Tadakazu Hisamatsu, Suk Kyun Yang, Qin Ouyang, Richard Geary, Janaka H De Silva, Rungsun Rerknimitr, Marcellus Simadibrata, Murdani Abdullah, Rupert WL Leong

Intest Res. 2019;17(3):285-310.

Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis

Soo-Young Na, Chang Hwan Choi, Eun Mi Song, Ki Bae Bang, Sang Hyoung Park, Eun Soo Kim, Jae Jun Park, Bora Keum, Chang Kyun Lee, Bo-In Lee, Seung-Bum Ryoo, Seong-Joon Koh, Miyoung Choi, Joo Sung Kim

Intest Res. 2023;21(1):61-87.